Evidence map›Paper›PMID 25317399›Full record

ArticleInternational journal of molecular and cellular medicine2014

Extraction and Identification of Antibacterial Secondary Metabolites from Marine Streptomyces sp. VITBRK2.

Benita Mercy Rajan, Krishnan Kannabiran

Abstract read
In one paragraph

Article in International journal of molecular and cellular medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Amicoumacins produced by the native citrus microbiome isolateApplied and environmental microbiology · 2025
    Article
  3. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Metabolic Comparison and Molecular Networking of Antimicrobials inInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Evaluation of the Cytotoxicity of Secondary Bioactive Compounds Produced byInternational journal of molecular and cellular medicine · 2024
    Article
  8. Article
  9. Marine-DerivedMicroorganisms · 2023
    Article
  10. Draft genome sequence of potato crop bacterial isolates and nanoparticles-intervention for the induction of secondary metabolites biosynthesis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  11. Overview on Strategies and Assays for Antibiotic Discovery.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  12. Review
  13. Article
  14. RhizosphericPlants (Basel, Switzerland) · 2022
    Article
  15. Soil-derivedHeliyon · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Benita Mercy RajanDivision of Biomolecules and Genetics, School of Biosciences and Technology, VIT University, India.
Krishnan KannabiranDivision of Biomolecules and Genetics, School of Biosciences and Technology, VIT University, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinomycetes were isolated from marine sediment samples collected from the east coast of Chennai, Tamil Nadu, India. Well diffusion and agar plug methods were used for the evaluation of antibiotic production by these isolates against drug resistant Methicillin- resistant Staphylococcus aureus (MRSA) and vancomycin resistant Enterococci (VRE). The potential isolate VITBRK2 was mass cultured for morphological and physiological characterization. The culturing conditions of the isolate were optimized and the recommendations of International Streptomyces Project were followed for the assimilation of carbon and nitrogen sources. The isolate was identified by comparing the properties with representative species in the key of Nonomura and Bergey's Manual of Determinative Bacteriology. Ethyl acetate extract prepared from the cell free culture broth of the isolate was analyzed using HPLC- diode array technique to characterize the metabolites and identify the antibiotics. VITBRK2 was found to be Gram-positive rod grey color aerial mycelium production. It was also non motile in nature with spiral spore chain morphology. VITBRK2 was identified as Streptomyces and designated as Streptomyces sp. VITBRK2. HPLC-DAD analysis showed the presence of indolo compounds (3- methyl-indole and 2-methyl- indole) along with amicoumacin antibiotic. The observed activity of Streptomyces sp. VITBRK2 against MRSA and VRE strains may be due to the presence of indolo compounds in the isolate. The results of this study suggested that secondary metabolites produced by Streptomyces sp. VITBRK2 could be used as a lead to control drug resistant bacterial pathogens.

Indexed as

anti-MRSA activityanti- VRE activitydrug resistanceindoloco-mpoundsStreptomyces sp. VITBRK2

Identifiers

PMID25317399
PMCPMC4170486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.